Dabigatran vs rivaroxaban for cerebral venous thrombosis
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares two blood thinners (dabigatran and rivaroxaban) to see which works better for treating a blood clot in the brain's veins. You may be eligible if you have a new diagnosis of this type of stroke and can start treatment within 14 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a new blood clot in a brain vein confirmed by a scan (CT or MRI)
- You can start the study medicine within 14 days of that scan
- You are able to swallow pills
- You do not have severe kidney problems, a bleeding disorder, or a condition that requires other blood thinners
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure to remove blood clots from the large veins that drain blood from the brain (called venous sinuses). It aims to improve symptoms like severe headaches, vision problems, and other effects of this condition for patients who have had symptoms for less than 3 weeks.
This trial tests whether taking blood-thinning pills (called DOACs) after initial treatment can safely treat blood clots in the veins of the brain. You may be able to join if you recently had this condition and start the pills within the first two weeks of treatment.
This trial tests two blood thinner medicines, edoxaban and rivaroxaban, in Chinese patients with a blood clot in a brain vein (cerebral venous thrombosis). It aims to see if these medicines are safe and work well.
This study looks at people with cerebral venous thrombosis who were treated with blood thinners taken by mouth (or started within the first 30 days). It uses observational data to understand how these treatments are used and what outcomes may follow.
This study tests two different blood-thinning medicines to see which is better at preventing another stroke in people who recently had a stroke with no clear cause. The goal is to find a treatment that works well and is safe for you.
This trial tests whether adding a medication called batroxobin to standard blood thinners can help treat blood clots in the veins of the brain better than blood thinners alone. It is for people who have been diagnosed in the last month and are not at high risk for bleeding.
Hear when a new Cerebral Venous Sinus Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.